Conferences
ASCO 2022: Defining Germline Genetics of Germ Cell Tumor: Implications for Genetic Testing and Clinical Management
June 5, 2022
ASCO 2022: A Phase 3 Trial of SHR3680 Versus Bicalutamide in Combination With ADT in Patients With High-Volume mHSPC
June 5, 2022